Unblinded: A Clinical Trial Podcast

In this week’s episode, Richard Young speaks to Vivienne van de Walle, medical director and founder of PT&R (an independent research site in the Netherlands), and Bree Burks, who joined @Veeva from a clinical research background where she supported nearly 1,000 trials across different roles. Sites have been voicing their concerns for years about how the industry runs clinical studies.

In this episode, Vivienne and Bree explain the tangible ways that sites (and patients) are hurt by inconsistent technology and the steps to make it better.

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

In this episode, Richard Young speaks with Bayer’s Head of Clinical Trial Management Services and Solutions, Emma Earl. With over 20 years of experience, Emma is perfectly positioned to comment on the rapid transformation in clinical operations and what changes are coming up on the horizon. Together they outline the major opportunities and the missing ingredients for delivering efficient and patient-centric clinical trials.

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Nicole Raleigh, Web Editor, Pharmaphorum

Guest: Chris Moore, President, Veeva Europe

We have a special episode for you this week! In a twist to our usual format, Nicole Raleigh of Pharmaphorum is in the host seat interviewing Veeva’s Chris Moore about his outlook on clinical trials in the U.K. and Europe. In a wide-ranging conversation, they cover the recent report from Lord O’Shaughnessy on U.K. life sciences, the impact of EU CTR, the potential and pitfalls of artificial intelligence, and what R&D organizations need next.

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, Vice President of Strategy, Veeva Vault CDMS

Guest: Patrick Nadolny, Global Head of Clinical Data Management, Sanofi

This week, Richard Young speaks to Patrick Nadolny, global head of clinical data management, Sanofi. In recent years, there’s been an explosion of new data from non-EDC sources like ePRO, imaging, and telemedecine. But, what does that mean for traditional EDC? In this episode, Richard and Patrick discuss the future of EDC – and whether we should retire the term all together. Plus, Patrick discusses new programs at Sanofi including what he calls “EDC-less” trials and a new “Act for Patients” initiative.

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Jim Reilly, VP, Development Cloud Strategy, Veeva

This week, Richard Young is joined by Jim Reilly, Veeva’s VP of Development Cloud Strategy. They discuss learnings from Veeva’s recent North American R&D and Quality Summit — including observations and trends from hundreds of biopharmas. Tune in to hear their takeaways on patient centricity, the future of digital trials, and major updates from Veeva announced at the event. 

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

Veeva website: https://go.veeva.com/l/28972/2023-08-22/9p7245

Does ChatGPT understand clinical trials? This week, Richard Young speaks to Andy Cooper, CEO of CluePoints, about going beyond the buzzword and making AI a reality in clinical data management. They discuss how to approach these technologies today and how to identify the areas of clinical trials where AI will be the most useful. Andy also deep dives on the different types of machine learning, how to train and develop trust with these tools, and why industry context is key when using AI-powered tools. 

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

Veeva website: https://go.veeva.com/l/28972/2023-08-22/9p7245

This week, Richard Young speaks to Tim Davis, vice president of strategy for MyVeeva for Patients. In recent years, decentralized clinical trials, patient centricity, and site centricity have become buzzwords for sponsors and CROs. This episode covers how to cut through the hype and focus on ideas that would both impact patient lives and make things easier for sites. As Tim explains, positive change starts with expanding patient choice during clinical trials.

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Rhona O’Donnell, VP, Data Management Systems and Standards, Novo Nordisk

This week, Richard Young is joined by Rhona O’Donnell, VP, Data Management Systems and Standards at Novo Nordisk. They discuss the evolution of the data management role, and how we can prepare for the future through collaboration and more effective training for the next generation. Richard and Rhona share their thoughts on the growing list of responsibilities facing data managers; why risk-based data management can help make trials more sustainable; the largest opportunities for time savings within the data management world; and the big initiatives that Novo Nordisk is working on to improve their data management processes. 

Get in touch with us if you would like to contribute to the podcast or share your feedback [email protected]

Subscribe to State of Digital Clinical Trials, a Veeva podcast to get new episodes as soon as they are released.

Spotify: https://lnkd.in/e5pJ7saP

Youtube: https://bit.ly/3quY9FY

Apple Podcasts: https://lnkd.in/efMTxybk

This week, Richard Young speaks to Alan Morgan, CEO Advisor of Excelya. In recent years, sponsors and CROs have invested heavily in “big data” tools for site selection and productivity. But, has that investment paid off? Richard and Alan discuss whether we’ve come any closer to truly patient-centric trials – and what we still have left to do. From partnering with patient advocacy groups to going back to the basics on data management, this episode covers some new industry initiatives that could make a positive difference for patients.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.

Host: Richard Young, VP, Strategy, Veeva Vault CDMS

Guest: Luis E. Torres, Head of Clinical Programming FSPx, Labcorp

This week, Richard Young speaks to Luis E. Torres, head of Clinical Programming FSPx at LabCorp. They discuss how data managers can prepare for the future of clinical trials by adopting new technologies and skills to keep decentralized clinical teams connected. Richard and Luis share their thoughts on designing studies and processes that support end-user needs; the shifting goal posts of data cleanliness and database build expectations; and why data managers are uniquely positioned to solve the “Rubik’s Cube” of challenges involving people, processes, and technology.

Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.